Zimmer Biomet Holdings (ZBH) Notes Payables (2011 - 2022)
Zimmer Biomet Holdings (ZBH) posted quarterly Notes Payables of $83.0 million for Q4 2022, up 39.97% quarter-over-quarter from $59.3 million in Q4 2014.
Zimmer Biomet Holdings (ZBH) Notes Payables (2011 - 2022) Analysis & Trends
Zimmer Biomet Holdings' Notes Payables history runs 5 years deep, the most recent figure standing at $83.0 million for Q4 2022.
- In Q4 2022, Notes Payables changed N/A year-over-year to $83.0 million; the TTM figure through Dec 2022 stood at $83.0 million (changed N/A YoY), while the FY2022 annual figure was $83.0 million, changed N/A from the prior year.
- Notes Payables for Q4 2022 stood at $83.0 million, up from $59.3 million in the prior quarter.
- The five-year high for Notes Payables was $83.0 million in Q4 2022, with the low at $83.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.41 Bn | 196.81 Bn | 7.27 Bn |
| 2 | Stryker | 126.30 Bn | 122.82 Bn | 4.50 Bn |
| 3 | Medtronic | 119.35 Bn | 110.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.65 Bn | 47.40 Bn | 1.35 Bn |
| 6 | Dexcom | 35.08 Bn | 33.13 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.67 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.19 Bn | 22.87 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.71 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.31 Bn | 18.90 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 83.00 Mn |
| Dec 31, 2014 | 59.30 Mn |
| Dec 31, 2013 | 500,000.00 |
| Dec 31, 2012 | 100,000.00 |
| Sep 30, 2012 | 300,000.00 |
| Jun 30, 2012 | 3.40 Mn |
| Mar 31, 2012 | 144.60 Mn |
| Dec 31, 2011 | 143.30 Mn |